메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학위논문
저자정보

정경원 (순천대학교, 순천대학교 대학원)

지도교수
나재운
발행연도
2015
저작권
순천대학교 논문은 저작권에 의해 보호받습니다.

이용수1

표지
AI에게 요청하기
추천
검색

이 논문의 연구 히스토리 (2)

초록· 키워드

오류제보하기
Ternary complexes are designed to deliver psiRNA-bcl2 and (KLA)4 peptide into tumor cells for cancer therapy. In this study, complexes containing psiRNA-bcl2 and (KLA)4 peptide with transferrin ligand-conjugated LMWSC (LMWSC-PEG-TfP) were prepared by electrostatic interaction. The delivered psiRNA-bcl2 induced gene-silencing in a nucleus of cancer cells, while (KLA)4 peptide inhibited tumor growth via mitochondrial apoptosis,
indicating that ternary complexes exert very strong synergistic effects on tumor growth suppression by acting on psiRNA-bcl2 and (KLA)4 peptide at the same time. In this study, ternary complexes having a targeting-ligand, transferrin (TfP), were found to be especially effective at binding to the TfP receptor rich cancer cells, HCT119.

The plasmid DNA (pDNA) in ternary complexes was completely condensed at various content of LMWSC-PEG-TfP (32?64 times more than pDNA) and released into cells. pDNA in the complexes was protected from DNase present on the exterior of cells. The size (165 nm?248 nm) of ternary complexes with LMWSC-PEG-TfP was increased, but surface charges (3 mV?4.5 mV) were decreased. These results likely occurred because the free amine-group of LMWSC decreased in response to conjugated transferrin. Moreover, transfected ternary complexes with LMWSC-PEG-TfP were not expressed in the normal cells (HEK293), but were over expressed in HCT119 cells. These findings indicate that the ternary complexes can be specifically targeted to HCT119 cancer cells. The ternary complexes had a low cytotoxicity in L929 cells at up to 4 μg of pDNA and high antitumor activities via a synergistic effect due to co-action of psiRNA and (KLA)4 peptide in HCT119 cells. Thus,
the ternary system is useful as a gene and peptide delivery system with high gene transfection, low toxicity, and high antitumor activities.

목차

Ⅰ. Introduction ?????????????????????????????????????????????????????????????????????????????????????1 Ⅱ. Materials and Methods ???????????????????????????????????????????????????????????????????5
2.1. Materials ???????????????????????????????????????????????????????????????????????????????????????5
2.2. Method ??????????????????????????????????????????????????????????????????????????????????????????6
2.2.1. Cell culture ????????????????????????????????????????????????????????????????????????????????6
2.2.2. Extraction of plasmid DNA ???????????????????????????????????????????????????????7
2.2.3. Synthesis of Synthesis of PEG-TfP-Fmoc?????????????????????????????????7 2.2.4. Synthesis of LMWSC-PEG-TfP-Fmoc??????????????????????????????????????7
2.2.5. Fmoc deprotection of LMWSC-PEG-TfP-Fmoc???????????????????????8 2.2.6. 1H-NMR spectra of LMWSC-PEG-TfP?????????????????????????????????????8 2.2.7. Preparation of ternary complexes ??????????????????????????????????????????????9
2.2.8. The size and zeta potential of ternary complexes??????????????????????9
2.2.9. Gel retardation assay of ternary complexes ?????????????????????????????10
2.2.10. pDNA protection and release assay of ternary complexes
?????????????????????????????????10
2.2.11. The transfection of ternary complexes???????????????????????????????????11
2.2.12. The Cytotoxicity and antitumor activity of ternary complexes
?????????????????????????????????????11
2.2.13. Gene silencing of ternary complexes with psiRNA-bc l2
Ⅲ. Results & Discussion ?????????????????????????????????????????????????????????????????????14
3.1. The scheme and action of ternary complexes ?????????????????????????????14 3.2. 1H-NMR spectra of LMWSC-PEG-TfP ????????????????????????????????????16
3.3. The gel retardation assay of ternary complexes ??????????????????????????19
3.4. The size and zeta potential of ternary complexes????????????????????????22
3.5. In-vitro transfection of ternary complexes ??????????????????????????????????28
3.6. In vitro cytotoxicity of ternary complexes???????????????????????????????????35
3.7. In vitro antitumor activities of ternary complexes???????????????????????39
3.8. In vitro western blot analysis of inhibited bcl-2 protein??????????????47 Ⅳ.Conclusion???????????????????????????????????????????????????????????????????????????????????????49 References????????????????????????????????????????????????????????????????????????????????????????????50 Korean Abstract??????????????????????????????????????????????????????????????????????????????????56 List of Publications ??????????????????????????????????????????????????????????????????????????????59 감사의 글 ???????????????????????????????????????????????????????????????????????????????????????????64

최근 본 자료

전체보기

댓글(0)

0